Intended for healthcare professionals

Endgames Case Report

A woman with generalised weakness, hypokalaemia, and metabolic acidosis

BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2545 (Published 12 April 2012) Cite this as: BMJ 2012;344:e2545
  1. H U Rehman, clinical associate professor
  1. 1Department of Medicine, Regina Qu’Appelle Health Region, Regina General Hospital, Regina, SK, Canada S4P 0W5
  1. Correspondence to: H U Rehman habib31{at}sasktel.net

A 31 year old woman presented with generalised weakness and muscle pain a week after having a flu-like illness, which had resolved completely. She had no diarrhoea, vomiting, urinary symptoms, joint pains, rashes, dry eyes, or dry mouth. Her medical history was unremarkable. Physical examination showed that she was well hydrated. Blood pressure was 102/55 mm Hg, pulse rate 88 beats/min. Muscle strength was 4/5 and 0/5 in the flexor muscle groups and 1/5 and 4/5 in the extensor muscle groups of the upper limbs and lower limbs, respectively. Deep tendon reflexes were brisk in the upper and lower limbs. No sensory deficit was found and the Babinski reflex test was negative. The rest of the physical examination was unremarkable.

Initial blood results were sodium 141 mmol/L (normal range 135-145), potassium 1.7 mmol/L (3.5-5.0), chloride 118 mmol/L (98-110), carbon dioxide 14 mmol/L (21-30), anion gap 11 mmol/L (10-20), urea 5.4 mmol/L (3.0-7.1), creatinine 69 µmol/L (60-130), creatine kinase 320 U/L (30-135). Urine results were pH 7.00 (5.0-8.0), sodium 47 mmol/L, potassium 13.2 mmol/L, chloride 52 mmol/L, calcium 1.50 mmol/L, and creatinine 3.9 mmol/L. Arterial blood gases on room air showed pH 7.31 (7.35-7.45), partial pressure of carbon dioxide 26 mm Hg (33-45), partial pressure of oxygen 111 mm Hg (75-100), bicarbonate 15 mmol/L (22-26), and base excess −12.1 mmol/L (−2.5 to 2.5). Erythrocyte sedimentation rate was 106 mm in the first hour (0-20). Complete blood count, thyroid function tests, and liver panel were normal.

She had a polyclonal increase in gammaglobulins 24.5g (6.0-18.0), IgG of 27.90 g (5.52-17.24), but normal IgA and IgM. Antinuclear antibodies were positive at 1:320, with a finely speckled staining pattern. Anti-smooth muscle antibodies were positive to a titre of 1:20. Anti-double stranded DNA antibodies were negative. She was positive for anti-Ro/SSA antibodies but negative for anti-La/SSB antibodies.

Renal ultrasound showed a stippled echogenic pattern of the renal pyramids related to nephrocalcinosis and small stones in the lower pole of the right kidney.

Parathyroid hormone was 1.92 ng/L (1.3-6.8); 25-hydroxyvitamin D3 59 nmol/L (25-250), rheumatoid factor 72 IU/mL (0-15), and caeruloplasmin 255 mg/L (200-600). Anti-cyclic citrullinated peptide antibodies were negative.

Questions

  • 1 What is the cause of hypokalaemia in this patient?

  • 2 What is the underlying cause of the metabolic abnormality?

  • 3 How would you treat this patient?

Answers

1 What is the cause of hypokalaemia in this patient?

Short answer

Distal renal tubular acidosis.

Long answer

Renal tubular acidosis comprises a group of disorders that result from tubular damage without glomerular damage. Primary and acquired forms have been described. There are three major types: type 1 or distal renal tubular acidosis, where the basic defect is impaired excretion of hydrogen ions; type 2 or proximal renal tubular acidosis, where the basic defect is a failure in bicarbonate reabsorption; and type 4 renal tubular acidosis, which is caused by apparent or real aldosterone deficiency or resistance and is most commonly associated with diabetes or interstitial nephritis. Hyperchloraemic metabolic acidosis with a normal anion gap, with or without associated defects in potassium homeostasis, and a urine pH greater than 5.5 in the presence of acidaemia are the hallmark features of renal tubular acidosis.

Kidneys respond to acidosis by increasing ammonium excretion in the urine. Failure of the kidney to increase ammonium output in the setting of acidosis indicates that a defect in renal acidification may be primarily responsible for the acidosis.1 Because renal ammonium excretion is not measured directly in most laboratories, urine anion gap provides an estimate of renal ammonium excretion. Urine anion gap should be negative in the presence of excess acidosis because of excess ammonium excretion. A positive urine anion gap indicates impairment of the urinary acidification process.

Distal renal tubular acidosis is an important cause of nephrolithiasis, nephrocalcinosis, osteodystrophy, and growth retardation in children.2 In one study of more than 300 patients with nephrocalcinosis, 20% had underlying distal renal tubular acidosis.3 Hypercalciuria and low urinary excretion of citrate are important factors in the development of nephrocalcinosis. In distal renal tubular acidosis, systemic acidosis leads to increased citrate reabsorption in the proximal tubule and thus to reduced urinary citrate excretion. Kidney stones and nephrocalcinosis are less common in proximal renal tubular acidosis because citrate reabsorption is often reduced and urinary citrate excretion increased.4

Our patient presented with profound hypokalaemia, non-anion gap metabolic acidosis, and a urine pH of 7.0 despite metabolic acidosis. A positive urine anion gap of 8.2 (urine sodium+urine potassium−urine chloride) meant impaired excretion of ammonia, thus confirming a diagnosis of an impaired renal acidification mechanism. Laing and Unwin provide a detailed discussion of the molecular pathophysiology of renal tubular acidosis.5

2 What is the underlying cause of the metabolic abnormality?

Short answer

Primary Sjögren’s syndrome.

Long answer

Acquired distal renal tubular acidosis can be associated with several underlying diseases including sickle cell disease, Sjögren’s syndrome, systemic lupus erythematosus, and drugs such as amphotericin B and lithium. Sjögren’s syndrome is defined as an autoimmune epithelitis characterised by lymphocytic infiltration of exocrine glands and epithelia. The lacrimal and salivary glands are commonly affected, resulting in dry eyes and xerostomia. A third of patients, however, present with systemic extraglandular manifestations.6 Renal tubular problems are common in primary Sjögren’s syndrome. In one study of 130 patients with primary Sjögren’s syndrome, 95 patients (73%) developed renal tubular acidosis, with 91 of them having distal renal tubular acidosis.7 Serological markers have a higher predictive value in the diagnosis of Sjögren’s syndrome than clinical symptoms and signs.8 Anti-Ro/SSA and anti-La/SSB antibodies are highly specific for Sjögren’s syndrome. Anti-Ro/SSA are the most prevalent antibodies in many autoimmune diseases, such as systemic lupus erythematosus, Sjögren’s syndrome/systemic lupus erythematosus overlap syndrome, subacute cutaneous lupus erythematosus, neonatal lupus, and primary biliary cirrhosis. Anti-La/SSB antibodies have the highest specificity (97%) for predicting Sjögren’s syndrome, however, and their presence is associated with internal organ manifestations or haematological abnormalities. Our patient did not have ocular or oral symptoms and did not undergo salivary gland biopsy so does not fulfil the diagnostic criteria for primary Sjögren’s syndrome. However, symptomatology has been challenged as a classification criterion and although sicca syndrome and dysfunction of the parotid and salivary glands are traditional hallmarks of Sjögren’s syndrome, these are not necessary for severe life threatening renal tubular acidosis and paralysis from Sjögren’s syndrome.6 9 Moreover, antibodies appear early in primary Sjögren’s syndrome, sometimes years before the first symptoms manifest.6 10

3 How would you treat this patient?

Short answer

Oral potassium and bicarbonate replacement.

Long answer

In distal renal tubular acidosis, adequate base should be provided to balance hydrogen ion production, usually 1-2 mmol/kg given as a mixture of sodium and potassium salts. Children require a higher dose because hydrogen ions are released from bone during the process of skeletal growth, so the required dose decreases progressively with age. Potassium citrate can also be used, and a dose of 4 mmol/kg per 24 hours is recommended in children. An appropriate dosage should correct most of the metabolic abnormalities, including hypercalciuria. It is important that hypercalciuria is prevented to avoid long term complications of nephrolithiasis and dystrophy. It is useful to monitor the urinary calcium to creatinine ratio and citrate to creatinine ratio so that the appropriate amount of alkali supplementation can be calculated. Treatment should be maintained throughout life.11

Patient outcome

Our patient’s symptoms and metabolic abnormalities improved with treatment. At follow-up she had no residual weakness, and her electrolytes and acid-base status were normal.

Notes

Cite this as: BMJ 2012;344:e2545

Footnotes

  • Competing interests: The author has completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declares: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work

  • Provenance and peer review: Not commissioned; externally peer reviewed.

  • Patient consent obtained.

References

View Abstract

Log in

Log in through your institution

Subscribe

* For online subscription